Therapy Areas: Central Nervous System
14 May 2019 - Saniona AB (STO:SANION), a biotechnology company focused on the central nervous system and eating disorders, announced on Monday the establishment of a Scientific Advisory Board (SAB) fo...
13 May 2019 - - US-based pharmaceutical company Bristol-Myers Squibb Company's (NYSE: BMY) Phase 3 CheckMate -498 trial evaluating Opdivo (nivolumab) plus radiation versus temozolomide ...
7 May 2019 - H. Lundbeck A/S (Lundbeck) (CPH:LUN), a global pharmaceutical company specialised in brain diseases, and Abide Therapeutics Inc(Abide) announced on Monday the signing of a definitive agre...
6 May 2019 - The board of directors of Allergan plc (NYSE:AGN) declared on Friday its dividend of USD0.74 per ordinary share for the second quarter of 2019.This cash dividend will be payable on 14 Jun...
Related Headlines